ASAPF (Aurora Spine) Debt-to-Asset : 0.36 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASAPF Aurora Spine Corp ASAPF
39 GF Score
Price $0.15
GF Value $0.23
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Aurora Spine Debt-to-Asset?

Aurora Spine ASAPF 39 Debt-to-Asset is 0.36 as of Mar. 2026. GuruFocus rates ASAPF with a GF Score™ of 39/100 and a GF Value™ of $0.23 (Possible Value Trap). The stock has 4 warning signs investors should review.

Aurora Spine's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $0.33 Mil. Aurora Spine's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $3.21 Mil. Aurora Spine's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2026 was $9.71 Mil. Aurora Spine's debt to asset for the quarter that ended in Mar. 2026 was 0.36.

Aurora Spine  (OTCPK:ASAPF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Aurora Spine Debt-to-Asset Related Terms

Aurora Spine Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Aurora Spine's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aurora Spine Debt-to-Asset Chart

Aurora Spine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.24 0.29 0.30 0.33 0.34

Aurora Spine Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.31 0.31 0.34 0.36

ASAPF vs ABT, SYK, MDT: Debt-to-Asset Comparison

For the Medical Devices subindustry, Aurora Spine's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aurora Spine Debt-to-Asset vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aurora Spine's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Aurora Spine's Debt-to-Asset falls into.


ASAPF
39GF Score
Aurora Spine Corp ASAPF
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aurora Spine Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Aurora Spine's Debt-to-Asset for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.294 + 3.246) / 10.407
=0.34

Aurora Spine's Debt-to-Asset for the quarter that ended in Mar. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.331 + 3.207) / 9.712
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.36 mean?
Aurora Spine (ASAPF) has a Debt-to-Asset of 0.36 as of Mar. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Aurora Spine and its competitors.
Is Aurora Spine's Debt-to-Asset too high?
Aurora Spine's current Debt-to-Asset is 0.36. Overall, Aurora Spine has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Spine's Debt-to-Asset compare to ABT and SYK?
Aurora Spine's Debt-to-Asset of 0.36 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Medical Devices & Instruments company?
A good Debt-to-Asset depends on the Medical Devices & Instruments industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Aurora Spine and its competitors. Aurora Spine's current Debt-to-Asset is 0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Spine stock overvalued right now?
Based on GuruFocus' analysis, Aurora Spine (ASAPF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.23, compared to a current price of $0.15 — trading 34.3% below its estimated fair value. The current Debt-to-Asset is 0.36. Aurora Spine's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Aurora Spine (ASAPF), the current Debt-to-Asset is 0.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aurora Spine (ASAPF) Overvalued in 2026?

Based on GuruFocus' analysis, Aurora Spine stock appears to be undervalued. The current stock price of $0.15 is trading 34.3% below its estimated GF Value™ of $0.23. GuruFocus considers Aurora Spine to be Possible Value Trap.

Key valuation signals for ASAPF:

  • Debt-to-Asset: 0.36
  • GF Value™: $0.23 vs. price of $0.15 (34.3% below fair value)
  • GF Score™: 39/100 with 4 warning signs

No single metric tells the full story. See the ASAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aurora Spine Business Description

Other Exchanges ASG:Canada
Address 20 Holly Street, Suite 300, Toronto, ON, CAN, M4S 3B1
Aurora Spine Corp is engaged in the development, manufacture, and sale of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.
39GF Score

Get the complete analysis for ASAPF

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price
$0.23
GF Value